Visipaque 320 MG/ML infus BTL 150ML
Ended Awarded Last action
- Contract number
- SPE2DR26FV6R9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,598
Award facts
- Contract value 100% obligated
- $1,597.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,597.96 to supply Visipaque 320 mg/mL infusion bottles (150 mL) with an ultimate completion date of December 9, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement across military and veteran healthcare systems. The company holds a significant Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX) valued at $999,999,999.00 through December 2026, which serves as the parent contract vehicle enabling the company to supply a comprehensive range of pharmaceutical products and medical supplies globally.
This delivery order represents a routine pharmaceutical supply transaction executed under AmerisourceBergen Drug Corp's broader DLA Troop Support Medical contract, which provides critical support to the Defense Health Agency and other federal healthcare systems. Visipaque is a contrast medium used in medical imaging procedures, and this order fulfills a specific medical supply need within the Defense Logistics Agency's pharmaceutical procurement operations. The company's consistent success in competitively awarded federal contracts and its extensive experience managing large-scale pharmaceutical distribution demonstrate its capability to meet the Defense Department's medical supply requirements across multiple therapeutic domains and geographic regions.
Quick answers
Who was awarded contract SPE2DR26FV6R9?
SPE2DR26FV6R9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 8, 2025.
How much is contract SPE2DR26FV6R9 worth?
The government has obligated $1,598 on SPE2DR26FV6R9.
Is contract SPE2DR26FV6R9 an order under another contract?
Yes. SPE2DR26FV6R9 is a delivery order under SPE2DR25D2214, an indefinite delivery contract.
Was contract SPE2DR26FV6R9 competed?
The extent of competition for SPE2DR26FV6R9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award